MKVCX
Price
$14.66
Change
-$0.09 (-0.61%)
Updated
Sep 20 closing price
OAKIX
Price
$26.91
Change
-$0.42 (-1.54%)
Updated
Sep 20 closing price
Ad is loading...

MKVCX vs OAKIX

Header iconMKVCX vs OAKIX Comparison
Open Charts MKVCX vs OAKIXBanner chart's image
MFS International Large Cap Value C
Price$14.66
Change-$0.09 (-0.61%)
VolumeN/A
CapitalizationN/A
Oakmark International Investor
Price$26.91
Change-$0.42 (-1.54%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
MKVCX vs OAKIX Comparison Chart
Loading...
VS
MKVCX vs. OAKIX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MKVCX is a Sell and OAKIX is a Buy.

FUNDAMENTALS
Fundamentals
OAKIX has more cash in the bank: 18.1B vs. MKVCX (6.63B). MKVCX pays higher dividends than OAKIX: MKVCX (2.39) vs OAKIX (1.84). MKVCX was incepted earlier than OAKIX: MKVCX (4 years) vs OAKIX (32 years). OAKIX (27.00) and MKVCX (26.00) have comparable annual turnover. OAKIX has a lower initial minimum investment than MKVCX: OAKIX (0) vs MKVCX (1000). MKVCX annual gain was more profitable for investors over the last year : 15.34 vs. OAKIX (4.96).
MKVCXOAKIXMKVCX / OAKIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence4 years32 years-
Gain YTD11.120-0.224-4,974%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets6.63B18.1B37%
Annual Yield % from dividends2.391.84129%
Returns for 1 year15.344.96310%
Returns for 3 years13.23-1.86-711%
Returns for 5 yearsN/A20.47-
Returns for 10 yearsN/A11.84-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSMMX20.75-0.01
-0.05%
Invesco Summit C
CCCNX6.09-0.01
-0.16%
Center Coast Brookfield Midstream Foc I
APDLX15.17-0.04
-0.26%
Artisan Value Advisor
RNWEX81.23-0.25
-0.31%
American Funds New World R4
BRKTX13.98-0.08
-0.57%
MFS Blended Research Em Mkts Eq R3